Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 1, 2003, Pages 429-436

  Marcet Palacios, Marcelo ^a,d   Graham, Kathryn ^a,c   Cass, Carol ^a,c   Befus, A Dean ^a,d   Mayers, Irvin ^a   Radomski, Marek W ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c CROSS CANCER INSTITUTE   (Canada)

^d Pulmonary Research Group   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; BACTERIUM LIPOPOLYSACCHARIDE; CYCLIC GMP; CYCLOOXYGENASE 2; GAMMA INTERFERON; GELATINASE B; GUANYLATE CYCLASE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CONTROL; GENETIC TRANSCRIPTION; MEASUREMENT; MESSENGER RNA SYNTHESIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPTIC SHOCK; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELLS, CULTURED; CYCLIC GMP; CYCLOOXYGENASE 2; ISOENZYMES; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 9; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXADIAZOLES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; QUINOXALINES; RATS; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 0141742351     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.050385     Document Type: Article

References (39)

1. Albert J, Radomski A, Soop A, Sollevi A, Frostell C, and Radomski MW (2003) Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers. Acta Anaesthesiol Scand 47:407-410.
2. Alexander C and Rietschel ET (2001) Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7:167-202.
3. Beckman JS, Beckman TW, Chen J, Marshall PA, and Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624.
4. Beckman JS and Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437.
5. Bone RC (1994) Gram-positive organisms and sepsis. Arch Intern Med 154:26-34.
6. Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47-95.
7. Dubois B, Starckx S, Pagenstecher A, Oord J, Arnold B, and Opdenakker G (2002) Gelatinase B deficiency protects against endotoxin shock. Eur J Immunol 32:2163-2171.
8. Eberhardt W, Akool el-S, Rebhan J, Frank S, Beck KF, Franzen R, Hamada FM, and Pfeilschifter J (2002) Inhibition of cytokine-induced matrix metalloproteinase 9 expression by peroxisome proliferator-activated receptor alpha agonists is indirect and due to a NO-mediated reduction of mRNA stability. J Biol Chem 277:33518-33528.
9. Eberhardt W, Beeg T, Beck KF, Walpen S, Gauer S, Bohles H, and Pfeilschifter J (2000) Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int 57:59-69.
10. Ermert M, Merkle M, Mootz R, Grimminger F, Seeger W, and Ermert L (2000) Endotoxin priming of the cyclooxygenase-2-thromboxane axis in isolated rat lungs. Am J Physiol Lung Cell Mol Physiol 278:L1195-L1203.
11. Fischer LG, Hollmann MW, Horstman DJ, and Rich GF (2000) Cyclooxygenase inhibitors attenuate bradykinin-induced vasoconstriction in septic isolated rat lungs. Anesth Analg 90:625-631.
12. Genersch E, Hayess K, Neuenfeld Y, and Haller H (2000) Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci 113:4319-4330.
13. Gilchrist M, Savoie M, Nohara O, Wills FL, Wallace JL, and Befus AD (2002) Nitric oxide synthase and nitric oxide production in in vivo-derived mast cells. J Leukoc Biol 71:618-624.
14. Gomez-Jimenez J, Salgado A, Mourelle M, Martin MC, Segura RM, Peracaula R, and Moncada S (1995) L-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23:253-258.
15. Grisham MB, Jourd'Heuil D, and Wink DA (1999) Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites:implications in inflammation. Am J Physiol 276:G315-G321.
16. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, and Lipton SA (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science (Wash DC) 297:1186-1190.
17. Gudi T, Hong GK, Vaandrager AB, Lohmann SM, and Pilz RB (1999) Nitric oxide and cGMP regulate gene expression in neuronal and glial cells by activating type II cGMP-dependent protein kinase. FASEB J 13:2143-2152.
18. Gudi T, Huvar I, Meinecke M, Lohmann SM, Boss GR, and Pilz RB (1996) Regulation of gene expression by cGMP-dependent protein kinase. Transactivation of the c-fos promoter. J Biol Chem 271:4597-4600.
19. Gudi T, Lohmann SM, and Pilz RB (1997) Regulation of gene expression by cyclic GMP-dependent protein kinase requires nuclear translocation of the kinase: identification of a nuclear localization signal. Mol Cell Biol 17:5244-5254.
20. Knuefermann P, Nemoto S, Baumgarten G, Misra A, Sivasubramanian N, Carabello BA, and Vallejo JG (2002) Cardiac inflammation and innate immunity in septic shock: is there a role for toll-like receptors? Chest 121:1329-1336.
21. Lee WJ, Shin CY, Yoo BK, Ryu JR, Choi EY, Cheong JH, Ryu JH, and Ko KH (2003) Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Glia 41:15-24.
22. Marshall HE and Stamler JS (2001) Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40:1688-1693.
23. Mayers I, Hurst T, Radomski A, Johnson D, Fricker S, Bridger G, Cameron B, Darkes M, and Radomski MW (2003) Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger. J Thorac Cardiovasc Surg 125:661-668.
24. Ohara Y, Peterson TE, and Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Investig 91:2546-2551.
25. Opdenakker G (2001) New insights in the regulation of leukocytosis and the role played by leukocytes in septic shock. Verh K Acad Geneeskd Belg 63:531-538; discussion 538-541.
26. Patel RP, McAndrew J, Sellak H, White CR, Jo H, Freeman BA, and Darley-Usmar VM (1999) Biological aspects of reactive nitrogen species. Biochim Biophys Acta 1411:385-400.
27. Pfeilschifter J, Eberhardt W, and Beck KF (2001) Regulation of gene expression by nitric oxide. Pflugers Arch 442:479-486.
28. Pugin J, Widmer MC, Kossodo S, Liang CM, Preas HL 2nd, and Suffredini AF (1999) Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 20:458-464.
29. Radomski A, Sawicki G, Olson DM, and Radomski MW (1998) The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br J Pharmacol 125:1455-1462.
30. Radomski MW, Vallance P, Whitley G, Foxwell N, and Moncada S (1993) Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 27:1380-1382.
31. Ritzel MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM, Ritzel RG, Mowles DA, Carpenter P, Chen XZ, et al. (2001) Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 276:2914-2927.
32. Ron D and Kazanietz MG (1999) New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J 13:1658-1676.
33. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, and Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90:7240-7244.
34. Strong VE, Mackrell PJ, Concannon EM, Naama HA, Schaefer PA, Shaftan GW, Stapleton PP, and Daly JM (2000) Blocking prostaglandin E2 after trauma attenuates pro-inflammatory cytokines and improves survival. Shock 14:374-379.
35. Szabo C, Zingarelli B, and Salzman AL (1996) Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxyrdtrite. Circ Res 78:1051-1063.
36. Szkotak AJ, Ng AM, Sawicka J, Baldwin SA, Man SF, Cass CE, Young JD, and Duszyk M (2001) Regulation of K(+) current in human airway epithelial cells by exogenous and autocrine adenosine. Am J Physiol Cell Physiol 281: C1991-C2002.
37. Tetsuka T, Daphna-Iken D, Miller BW, Guan Z, Baier LD, and Morrison AR (1996) Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J Clin Investig 97:2051-2056.
38. Titheradge MA (1999) Nitric oxide in septic shock. Biochim Biophys Acta 1411:437-455.
39. Webber D (1998) Restored credibility for sepsis therapeutics? Nat Biotechnol 16:1303.